Introduction Nivolumab, a groundbreaking immunotherapy drug, has transformed cancer treatment by harnessing the body’s immune system to fight tumors. Marketed under the brand name Opdivo, it is a leading PD-1 inhibitor used to treat various cancers, including melanoma, lung cancer, and renal cell carcinoma. The Nivolumab Market is experiencing significant growth, driven by...